Cantor Fitzgerald analyst William Tanner reiterated his Overweight rating and $32 price target on TherapeuticsMD (TXMD) ahead of an expected meeting with the U.S. Food...
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) downgraded to Underweight from Equal Weight...
Merger talks between Sprint (S) and T-Mobile (TMUS) continue despite reports earlier in the week saying they are dead, CNBC's David Faber reports. While the...
In a regulatory filing, it was disclosed that Vintage Capital Management, which currently own approximately 6% of the common stock of Rent-A-Center, said in a...
Johnson & Johnson disclosed last night that it received subpoenas or requests for information related to opioids marketing practices from four state Attorneys General: New...
UP AFTER EARNINGS: Cardtronics (CATM), up 16.1%... Floor & Decor (FND), up 11.2%... Varonis (VRNS), up 9.6%... Molina Healthcare (MOH), up 9.4%... MercadoLibre (MELI), up...
Piper Jaffray analyst Edward Tenthoff raised his price target for Alnylam Pharmaceuticals (ALNY) to $188 saying today's Phase III Apollo results confirm patisiran's superior efficacy...